More studies of longer duration are needed to examine body composition and fat distribution changes on CFTR modulators in the setting of unintended weight gain and the development of overweight and obesity on these drugs. The gene discussed is CFTR; the disease is obesity due to melanocortin 4 receptor deficiency.